Page last updated: 2024-08-24

triazoles and razoxane

triazoles has been researched along with razoxane in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Larsen, AK; Lemke, K; Poindessous, V; Skladanowski, A	1

Other Studies

1 other study(ies) available for triazoles and razoxane

Article	Year
The antitumor triazoloacridone C-1305 is a topoisomerase II poison with unusual properties. Molecular pharmacology, 2004, Volume: 66, Issue:4 Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Catalytic Domain; DNA; DNA Topoisomerases, Type II; Drug Interactions; Drug Screening Assays, Antitumor; Gene Expression; HL-60 Cells; Humans; Mice; Multidrug Resistance-Associated Proteins; NIH 3T3 Cells; Plasmids; Razoxane; Spheroids, Cellular; Time Factors; Topoisomerase II Inhibitors; Triazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2004

Article

Year

The antitumor triazoloacridone C-1305 is a topoisomerase II poison with unusual properties.

Molecular pharmacology, 2004, Volume: 66, Issue:4

Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Catalytic Domain; DNA; DNA Topoisomerases, Type II; Drug Interactions; Drug Screening Assays, Antitumor; Gene Expression; HL-60 Cells; Humans; Mice; Multidrug Resistance-Associated Proteins; NIH 3T3 Cells; Plasmids; Razoxane; Spheroids, Cellular; Time Factors; Topoisomerase II Inhibitors; Triazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2004